Research carried out in Montreal is providing a better understanding of how an essential component of the immune system works ...

The National Institute of Scientific Research (INRS) inaugurated a new Quebec health research network on Thursday dedicated ...

At the Montreal Chest Institute (MCI), research is no longer a separate entity—it’s becoming an integral part of daily care.

Icotrokinra met all primary endpoints in the studies, demonstrating significant skin clearance and clinical remission.

MONTREAL, March 07, 2025--(BUSINESS WIRE)--Innovaderm, a leading clinical research organization (CRO), is excited to reveal a major rebranding to Indero, with immediate effect. The new brand identity ...

A copy of the abstract can be viewed on the ACC25 website, on the Online Planner here.

Proportion increases when considering off-label use but drops when considering drugs with substantial clinical benefit.

After 2 positive trials, low-dose colchicine’ got the FDA nod for CV reduction but then the CLEAR SYNERGY trial found no ...

Montreal-based CRO Innovaderm Research has rebranded immediately to Indero, the latest change in an effort to become dually ...

MONTREAL--(BUSINESS WIRE)--Innovaderm, a leading clinical research organization (CRO), is excited to reveal a major rebranding to Indero, with immediate effect. The new brand identity reinforces ...

Patients enroll in phase 2 oncology trials seeking access to promising new treatments, but the risk-benefit assessments and the likelihood of receiving a therapy that ultimately gains FDA approval ...

Initial clinical readout from Phase 1 RP-3467 (Polθ ATPase/helicase inhibitor) POLAR trial expected in Q3 2025 Initial clinical readout from Phase 1 RP-1664 (PLK4 inhibitor) LIONS trial expected ...